Home > Healthcare > Analytical Instruments > Immunoassay > Immunofluorescence Assay Market
Immunofluorescence Assay Market Size
- Report ID: GMI9818
- Published Date: Jun 2024
- Report Format: PDF
Immunofluorescence Assay Market Size
Immunofluorescence Assay Market was valued at around USD 2.6 billion in 2023 and is estimated to grow at 5.1% CAGR from 2024 to 2032. Immunofluorescence assay (IFA) is a laboratory technique used to detect the presence of specific antigens or antibodies in a sample by using fluorescently labeled antibodies.
The global incidence of chronic diseases such as diabetes, cancer, cardiovascular diseases, and autoimmune disorders is rising, necessitating regular monitoring and diagnostic testing, The demand for accurate and efficient diagnostic tools such as IFAs has surged with the increasing patient population, a trend expected to continue stimulating the market growth. Furthermore, recent technological advancements in immunofluorescence assays (IFAs) have significantly enhanced their sensitivity and specificity, improving their reliability for detecting low-abundance biomarkers. Automated systems have streamlined the assay process, reduced human error, and increased throughput, particularly benefiting high-volume clinical laboratories, and driving market growth.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Immunofluorescence Assay Market Size in 2023: | USD 2.6 Billion |
| Forecast Period: | 2024 - 2032 |
| Forecast Period 2024 - 2032 CAGR: | 5.1% |
| 2032 Value Projection: | USD 4 Billion |
| Historical Data for: | 2021 - 2023 |
| No. of Pages: | 167 |
| Tables, Charts & Figures: | 284 |
| Segments covered: | Product, Type, Application, End-use, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Immunofluorescence Assay Market Scope
